State of Wisconsin Investment Board
BOLT icon

State of Wisconsin Investment Board’s Bolt Biotherapeutics BOLT Stock Holding History

State of Wisconsin Investment Board’s Portfolio BOLT Stock Details BOLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-750
Closed -$190K – 2161
2021
Q3 		$190K Buy
750
+137
+22% +$38.7K ﹤0.01% 2078
2021
Q2 		$190K Buy
+613
New +$249K ﹤0.01% 2037

Other funds holding BOLT

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

State of Wisconsin Investment Board's BOLT Position: Q4 2021 in Review

State of Wisconsin Investment Board sold out of Bolt Biotherapeutics (BOLT) in Q4 2021, closing a stake of 750 shares — an estimated $190K sold.

State of Wisconsin Investment Board first reported a position in BOLT in Q2 2021 and held it in 2 quarters. The position peaked at $190K in Q3 2021. 62 funds tracked by Wall St. Rank hold BOLT as of Q4 2021.

  • State of Wisconsin Investment Board reported no remaining Bolt Biotherapeutics position as of Q4 2021 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 750 Bolt Biotherapeutics shares in Q4 2021, an estimated $190K.
  • State of Wisconsin Investment Board first reported a position in Bolt Biotherapeutics in Q2 2021 and held it in 2 quarters.
  • State of Wisconsin Investment Board's Bolt Biotherapeutics position peaked at $190K in Q3 2021.
  • 62 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q4 2021.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2021, filed 11 Feb 2022.